Janus Henderson Group
IMUX icon

Janus Henderson Group’s Immunic IMUX Stock Holding History

Janus Henderson Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-268,908
Closed -$2.69M – 2511
2024
Q4 		$2.69M Sell
268,908
-241,020
-47% -$3.04M ﹤0.01% 1162
2024
Q3 		$8.44M Sell
509,928
-197,456
-28% -$2.81M ﹤0.01% 720
2024
Q2 		$7.96M Buy
707,384
+8,083
+1% +$100K ﹤0.01% 715
2024
Q1 		$9.27M Buy
+699,301
New +$9.09M 0.01% 710
2022
Q4 		– Sell
-62,876
Closed -$1.98M – 2477
2022
Q3 		$1.98M Sell
62,876
-21,506
-25% -$900K ﹤0.01% 1307
2022
Q2 		$2.92M Buy
84,382
+51,083
+153% +$3.27M ﹤0.01% 959
2022
Q1 		$3.76M Buy
+33,299
New +$3.85M ﹤0.01% 1071

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janus Henderson Group's IMUX Position: Q1 2025 in Review

Janus Henderson Group sold out of Immunic (IMUX) in Q1 2025, closing a stake of 268,908 shares — an estimated $2.69M sold.

Janus Henderson Group first reported a position in IMUX in Q1 2022 and held it in 7 quarters. The position peaked at $9.27M in Q1 2024. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.

  • Janus Henderson Group reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 268,908 Immunic shares in Q1 2025, an estimated $2.69M.
  • Janus Henderson Group first reported a position in Immunic in Q1 2022 and held it in 7 quarters.
  • Janus Henderson Group's Immunic position peaked at $9.27M in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.